Ascendis Pharma Officer Files Form 144 to Sell $810K in ADSs
Ascendis Pharma A/S
Subscribe to track ASND
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice of Proposed Sale Company: Ascendis Pharma A/S ($ASND) Insider: Mads Bodenhoff (Officer) Securities: 3,000 American Depositary Shares Estimated Value: $810,562.66 (~$270.19/share) Broker: Merrill Lynch Acquisition: Warrant exercise (Cash payment, 09/08/2026) Approximate Sale Date: 09/08/2026
Comprehensive Analysis
Form 144 Filing Analysis: Ascendis Pharma A/S ($ASND)
Transaction Overview
- Filer: Mads Bodenhoff, Officer
- Security: American Depositary Shares (ADS)
- Number of Shares Proposed for Sale: 3,000
- Aggregate Market Value: $810,562.66 (~$270.19 per ADS)
- Shares Outstanding: 66,189,926
- Approximate Date of Sale: September 8, 2026
- Broker: Merrill Lynch
Nature of Acquisition
- Acquisition Date: September 8, 2026
- Nature of Acquisition: Warrant exercise
- Payment Method: Cash
- Prior 3-Month Sales: None reported
Significance and Context
This Form 144 filing represents a standard notification of intent to sell shares resulting from a warrant exercise. The 3,000 ADSs represent less than 0.01% of total shares outstanding, indicating minimal market impact and standard liquidity management by the insider.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.